Issues in the management of preterm labor

Journal of Obstetrics and Gynaecology Research

Volumn 31, Issue 5, 2005, Pages 354-358

  Resnik, Robert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTIBIOTIC AGENT; ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CORTICOTROPIN RELEASING FACTOR; FIBRONECTIN; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYPROGESTERONE; INDOMETACIN; MAGNESIUM SULFATE; OXYTOCIN ANTAGONIST; PROGESTERONE; PROSTAGLANDIN SYNTHASE INHIBITOR; SCLEROPROTEIN; UTERUS SPASMOLYTIC AGENT;

AFRICAN AMERICAN; BISHOP SCORE; BODY MASS; CIGARETTE SMOKING; COCHRANE LIBRARY; ENCEPHALOMALACIA; FEMALE; HEALTH STATISTICS; HUMAN; INFERTILITY THERAPY; INTRAUTERINE GROWTH RETARDATION; INTRAUTERINE INFECTION; LUNG DYSPLASIA; MULTIPLE PREGNANCY; NECROTIZING ENTEROCOLITIS; PLACENTA PREVIA; PREECLAMPSIA; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK FACTOR; SCORING SYSTEM; STILLBIRTH; SURVIVAL RATE; TRANSVAGINAL ECHOGRAPHY; UNITED KINGDOM; UNITED STATES; URINARY TRACT INFECTION; UTERINE CERVIX DILATATION; UTERINE CERVIX INCOMPETENCE; UTERUS CONTRACTION; VAGINA BLEEDING; VERY LOW BIRTH WEIGHT;

ADRENAL CORTEX HORMONES; CERVIX UTERI; FEMALE; FETUS; FIBRONECTINS; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RISK FACTORS; TOCOLYTIC AGENTS; UTERINE CONTRACTION;

EID: 27744461951     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2005.00302.x     Document Type: Review

References (36)

1. Meis PJ, Goldenberg RL, Mercer BM et al. The preterm prediction study: Risk factors for indicated preterm birth. Am J Obstet Gynecol 1998; 178: 562-567.
2. Goldenberg RL, Iams JD, Mercer BM et al. The preterm prediction study: The value of new vs. standard risk factors in predicting early and all spontaneous preterm births. Am J Public Health 1998; 88: 233-238.
3. Martin JA, Hamilton BE, Ventura SJ et al. Births: Final Data for 2001. National Vital Statistics Report, Vol. 51, No. 2. Hyattsville, MD: National Center for Health Statistics, 2002.
4. Martin JA, Hamilton BE, Ventura SJ et al. Births: Final Data for 2000. National Vital Statistics Report, Vol. 50, No. 5. Hyattsville, MD: National Center for Health Statistics, 2002.
5. Centers for Disease Control and Prevention. Contribution of assisted reproductive technology and ovulation-inducing drugs to triplets and higher order multiple births-United States, 1980-1997. MMWR Morb Mortal Wkly Rep 2000; 49: 535-538.
6. Moore TM, Iams JD, Creasy RK et al. Diurnal and gestational patterns of uterine activity in normal human pregnancy. Obstet Gynecol 1994; 83: 517-523.
7. Iams JD, Newman RB, Thorn EA et al. Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med 2002; 346: 250-255.
8. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Assessment of risk factors for preterm birth; clinical management guidelines for obstetricians-gynecologists. Obstet Gynecol 2001; 98: 709-716.
9. US Preventive Services Task Force. Home uterine activity monitoring for preterm labor. JAMA 1993; 270: 371-376.
10. Newman RB for the NICHD Maternal-Fetal Medicine Network. The preterm prediction study: Comparison of the cervical score and Bishop Score for the prediction of spontaneous preterm birth (Abstract No. 293). J Soc Gynecol Invest 1997; 4: 152A.
11. Iams JD, Goldenberg RL, Meis PJ et al. The length of the cervix and the risk of spontaneous preterm delivery. N Engl J Med 1996; 334: 567-572.
12. Mercer BM, Goldenberg RL, Das A et al. The preterm prediction study: A clinical risk assessment system. Am J Obstet Gynecol 1996; 174: 1885-1893.
13. Leitich H, Kaider A. Fetal fibronectin - how useful is it in the prediction of preterm birth? BJOG 2003; 110(Suppl 20): 66-70.
14. Honest H, Bachmann LM, Gupta JK et al. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: Systematic review. BMJ 2002; 325: 301.
15. Iams JD, Goldenberg RL, Mercer BM et al. The preterm prediction study: Recurrence risks of spontaneous preterm birth. Am J Obstet Gynecol 1998; 178: 1035-1040.
16. Gomez R, Romero R, Medina L et al. Cervicovaginal fibronectin improves the prediction of preterm labor based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. Am J Obstet Gynecol 2005; 192: 350-359.
17. Iams JD. Prediction and early detection of preterm labor. Obstet Gynecol 2003; 101: 402-412.
18. Berkman ND, Thorp TM Jr, Lohr KN et al. Tocolytic Treatment for the management of preterm labor: A review of the evidence. Am J Obstet Gynecol 2003; 188: 1648-1659.
19. Liggins GC, Howie RN. A controlled trial of antepartum corticosteroid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515-525.
20. US Department of Health and Human Services. Report on the Consensus Development Conference on the effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Pub. No. 95-3784, November, 1994.
21. Committee on Obstetric Practice. ACOG Committee Opinion: Antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol 2002; 99: 871-873.
22. RCOG Guidelines. No. 7. ACS to prevent respiratory distress syndrome. London: RCOG, 1996.
23. Guinn DA, Atkinson MW, Sullivan L et al. Single vs. weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial. JAMA 2001; 286: 1581-1587.
24. Antenatal Corticosteroids Revisited: Repeat Courses. NIH Concensus Statement. August 17, 2000.
25. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad spectrum antibiotics for spontaneous preterm labor: The ORACLE II randomized trial. ORACLE Collaborative Group. Lancet 2001; 357: 989-994.
26. King J, Flenady V. Antibiotics for preterm labour with intact membranes. Cochrane Database Syst Rev 2000; CD000246.
27. Klein LL, Gibbs RS. Use of microbial cultures and antibiotics in the prevention of infection-associated preterm birth. Am J Obstet Gynecol 2004; 190: 1493-1502.
28. Meis PJ, Klebanoff M, Thom E et al. Prevention of recurrent preterm labor by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 2379-2385.
29. da Fonseca EB, Bittar RE, Carvalho MHB et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of preterm birth in women at increased risk: A randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419-424.
30. ACOG Committee Opinion. Use of progesterone to reduce preterm birth. Obstet Gynecol 2003; 102: 1115-1116.
31. Rust OA, Atlas RO, Reed J et al. Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: Why cerclage therapy may not help. Am J Obstet Gynecol 2001; 185: 1098-1105.
32. To MS, Alfirevic Z, Heath VC et al. Cervical cerclage for prevention of preterm delivery in women with short cervix: Randomized controlled trial. Lancet 2004; 363: 1849-1853.
33. Berghella V, Odibo AO, Tolosa JE. Cerclage for prevention of preterm birth in women with a short cervix found on transvaginal ultrasound examination: A randomized trial. Am J Obstet Gynecol 2004; 191: 1311-1317.
34. Drakeley AJ, Roberts D, Alfirevic Z. Cervical cerclage for prevention of preterm delivery: A meta-analysis of randomized trials. Obstet Gynecol 2003; 102: 621-627.
35. Belej-Rak T, Okun N, Windrim R et al. Effectiveness of cervical cerclage for a sonographically shortened cervix: A systematic review and meta-analysis. Am J Obstet Gynecol 2003; 189: 1679-1687.
36. Arias E, MacDorman MF, Strobino DM, Guyer B. Annual summary of Vital Statistics-2002. Pediatrics 2003; 112: 1215-1230.